News & Articles

OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

The new medium promises to boost and optimize the production of AAV in Sf9 insect cells

Register for this webinar to learn more about underlying chemistry considerations for sample preparation and chromatography of PFAS and GenX compounds

These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19

This initiative step aims to help healthcare workers and researchers as they battle the global pandemic

Learn how an institute in the US is developing the latest patient-derived 3D cancer cell cultures for use in precision medicine

The collaboration aims to develop novel, targeted treatments to address significant unmet needs

Coronavirus is said to be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, which distinguishes it from influenza

The event has been rescheduled to take place from September 8-10, 2020, at London ExCeL

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection

Register now to join world-leading researchers online, March 31-April 2, as the global science industry pulls together at this critical time

Clinical laboratories can immediately begin using this kit to detect SARS-CoV-2

Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Join SelectScience online from March 31 - April 2 to hear the latest from world-leading researchers

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic